/Companies

Gild

Acquired

8 known investors

Find your way into Gild

Sign up to see every warm intro you have to Gild

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Gild team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Acquired by Citadel October 2016 · terms undisclosed — undisclosed · source ↗

Gilead is a biopharmaceutical company that develops medicines across virology, oncology, and inflammation, with over 25 medicines offered globally and 53 clinical programs. It also funds philanthropic HIV programs in the U.S. and works to advance health equity.

Investors · 8

Also in the syndicate · 1

SAP Ventures

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Gild do?
Gilead is a biopharmaceutical company that develops medicines across virology, oncology, and inflammation, with over 25 medicines offered globally and 53 clinical programs. It also funds philanthropic HIV programs in the U.S. and works to advance health equity.
Who are Gild's investors?
Gild's investors include Baseline Ventures, Globespan Capital Partners, Milliways Ventures, Baseline, Correlation Ventures, Drive Capital, Menlo Ventures.